Announcements

Calix, Inc. filed a current report with the SEC on November 2, 2026, announcing the public dissemination of a stockholder letter containing financial results for the third quarter ended September 26, 2026.

iSpecimen Inc. filed a Form 8-K on November 2, 2026, reporting the final voting results from the reconvened special meeting of stockholders held on October 30, 2026, at which shareholders approved a proposal to effect a reverse stock split of the company's common stock.

Cooper-Standard Holdings Inc. filed a Form 8-K on November 2, 2026, disclosing that it entered into a new Section 382 Rights Agreement dated November 2, 2026, with Broadridge Corporate Issuer Solutions, LLC as Rights Agent, replacing an expiring prior rights agreement effective at the …

Keen Vision Acquisition Corporation filed a Form 8-K on November 2, 2026, disclosing that it issued a $30,000 unsecured promissory note to its sponsor on October 27, 2026, and extended its business combination deadline to January 27, 2027.

HCA Healthcare, Inc. filed a Form 8-K on November 2, 2026, disclosing that its wholly owned subsidiary HCA Inc. commenced a public offering of senior unsecured notes and issued notice of its intent to redeem all $1.200 billion of its outstanding 4.500% senior notes …

Qualcomm Incorporated President and CEO Cristiano R. Amon filed a Form 4 on November 2, 2026, reporting restricted stock unit conversions and share withholdings tied to a vesting event on October 31, 2026.

VIANIQ Holdings Limited, formerly known as CubeBio Holdings Limited, filed a Form 6-K on November 2, 2026, disclosing a corporate name change that became effective on October 21, 2026, following approval by the company's sole shareholder.